![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10193 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-PRL1/PTP4A1 |
克隆性 | |
靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
宿主 | 詳見(jiàn)說(shuō)明書(shū) |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human PTP4A1(22-32aa) |
產(chǎn)品訂購(gòu)信息:
英文名稱(chēng) Anti-PRL1/PTP4A1
中文名稱(chēng) 肝再生磷酸酯酶1抗體費(fèi)用
別 名 HH 72; HH72; Hypothetical protein DKFZp779M0721; PRL 1; PRL-1; PRL1; Protein tyrosine phosphatase PTPCAAX1; Protein tyrosine phosphatase type IVA 1; Protein tyrosine phosphatase type IVA member 1; Protein-tyrosine phosphatase 4a1; Protein-tyrosine phosphatase of regenerating liver 1; PTP(CAAXI); Ptp4a1; PTPCAAX1; TP4A1_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 25kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PTP4A1(22-32aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
肝再生磷酸酯酶1抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 PTP4A1 belongs to a small class of prenylated protein tyrosine phosphatases (PTPs), which contains a PTP domain and a characteristic C-terminal prenylation motif. PTPs are cell signaling molecules that play regulatory roles in a variety of cellular processes. This tyrosine phosphatase is a nuclear protein, but may primarily associate with plasma membrane. The surface membrane association of this protein depends on its C-terminal prenylation. Overexpression of this gene in mammalian cells conferred a transformed phenotype, which implicated its role in the tumorigenesis. Studies in rat suggested that this gene may be an immediate-early gene in mitogen-stimulated cells.
Function : Opiorphin is an endogenous inhibitor of neprilysin and aminopeptidase N. Inhibits the breakdown of substance P, Mca-BK2 and Met-enkephalin by neprilysin in vitro with IC(50) values of 29 uM, 33 uM and 33 uM respectively. Inhibits the breakdown of Ala-pNA by aminopeptidase N in vitro with an IC(50) of 65 uM. Has a potent analgesic effect when administered to rats by intravenous injection.
Subunit : Secreted.
Subcellular Location : Abundantly expressed in lacrimal gland where it found in the secretory endpieces. Also expressed at modest levels in the submandibular gland.
ompF(putative outer membrane porin F protein) 小腸耶爾森氏菌膜通道蛋白抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-ARIP2a 激活素受體2A抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-ASK1(Ser967) 磷酸化細(xì)胞凋亡信號(hào)調(diào)節(jié)激酶1抗體 規(guī)格 0.2ml
uPA 濃縮液 0.1ml 進(jìn)口分裝
UBTD1 英文名稱(chēng): 泛素結(jié)構(gòu)域蛋白1抗體 0.2ml
DPH2 英文名稱(chēng): 白喉酰胺生物合成樣蛋白2抗體 0.2ml
Anti-ARIP2a 激活素受體2A抗體Multi-class antibodies規(guī)格: 0.2ml
TTF-1 (Thyroid Transcription Factor-1) 甲狀腺核轉(zhuǎn)錄因子-1抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Caspase-1(actived) 天冬氨酸-胱氨酸特異性蛋白酶家族抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh PD-1/CD279 程序性死亡1抗體 規(guī)格 0.1ml
FCGR2B Kit Human 人 CD32b / FCGR2B ELISA配對(duì)抗體 ELISA
TSBP 英文名稱(chēng): 特異蛋白抗體 0.2ml
Alpha s2 Casein 英文名稱(chēng): α-s2酪蛋白抗體 0.2ml
Anti-Caspase-1(actived) 天冬氨酸-胱氨酸特異性蛋白酶家族抗體Multi-class antibodies規(guī)格: 0.1ml
EPOR ELISA Kit 大鼠紅細(xì)胞生成素受體Multi-class antibodies規(guī)格: 48T
Anti-APS(Ser598)/FITC 熒光素標(biāo)記磷酸化APS抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh FAM3B/PANDER *衍生因子抗體 規(guī)格 0.2ml
ALP ELISA Kit 大鼠堿性磷酸酶 96T
Phospho-MAP3K8 (Thr290) 英文名稱(chēng): 磷酸化原活化蛋白激酶激酶8抗體 0.1ml
Annexin A10 英文名稱(chēng): 膜粘連蛋白10抗體 0.1ml
Anti-APS(Ser598)/FITC 熒光素標(biāo)記磷酸化APS抗體IgGMulti-class antibodies規(guī)格: 0.2ml
C2C12, 小鼠肌原細(xì)胞
CatS2 家貓皮膚成纖維樣細(xì)胞
IL12A & IL12B Others Human 人 IL12A & IL12B Heterodimer 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0070CRFK(貓腎細(xì)胞)5×106cells/瓶×2
支原體PCR檢測(cè)試劑盒MYCO
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞(傣族);KM9403 人臍動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
CL-0100HEC-1-B(人子宮內(nèi)膜腺癌細(xì)胞)5×106cells/瓶×2
CSF2RB Others Rat 大鼠 CD131 / CSF2RB / IL3RB / IL5RB 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人海馬趾星形膠質(zhì)細(xì)胞裂解物HA-h L
OVCaR-3細(xì)胞,人細(xì)胞 菜青蟲(chóng)卵巢細(xì)胞,Pr-HNV8細(xì)胞 神經(jīng)膠質(zhì)細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
CEM/C1(人急性淋巴細(xì)胞細(xì)胞) 5×106cells/瓶×2
HUtSMC Pellet 人細(xì)胞團(tuán)塊 > 1 mio.cells 人表皮角質(zhì)細(xì)胞-cDNAHEK-acDNA
肝再生磷酸酯酶1抗體費(fèi)用 C2C12, 小鼠肌原細(xì)胞
CatS2 家貓皮膚成纖維樣細(xì)胞
IL12A & IL12B Others Human 人 IL12A & IL12B Heterodimer 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0070CRFK(貓腎細(xì)胞)5×106cells/瓶×2
支原體PCR檢測(cè)試劑盒MYCO
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞(傣族);KM9403 人臍動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 肝再生磷酸酯酶1抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件;
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴(lài)氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)肝再生磷酸酯酶1抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線(xiàn),計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。